Navigation Links
Royalty Pharma Statement Regarding Withdrawal of Elan Lawsuit
Date:6/10/2013

NEW YORK, June 10, 2013 /PRNewswire/ -- Royalty Pharma announced today that Elan voluntarily withdrew the lawsuit it had filed on an expedited basis only one week ago in New York federal court.   That suit claimed that Royal Pharma's tender offer disclosures were inadequate.  As explained in Royalty Pharma's response to Elan's complaint, served on Elan just yesterday, Elan's claims were entirely without merit, and in any event were rendered irrelevant by the amended disclosures Royalty Pharma filed Friday, June 7.  Faced with the prospect of an embarrassing loss, Elan has chosen to walk away.  The voluntary withdrawal confirms that Royalty Pharma's disclosures have been full and accurate, and that investors have all the information they require to consider Royalty Pharma's highly compelling tender offer.

By voluntarily dismissing its claim today, Elan also avoids having to defend in open court its conduct with respect to the ADS record date.  Indeed, it was less than two hours after Royalty Pharma served discovery requests seeking to learn more information regarding Elan's board and senior management actions around the record date that Elan promptly dismissed its lawsuit.  Elan had also refused to allow Royalty Pharma to file publicly any of the emails or other documents it obtained from Elan in connection with its defense of Elan's lawsuit, or even to file Royalty Pharma's brief without redacting information from Elan's internal emails about the ADS record date.

Elan now claims the ADS record date has always been May 23, despite documentary proof that on May 22 and May 23, Elan's investor relations department told numerous investors the record date would be June 13.  Royalty Pharma believes that many investors have been deprived of their right to vote at the June 17 extraordinary general meeting as a result of Elan's actions relating to the record
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Royalty Rates Take Center Stage in Biopharma Dealmaking
2. Royalty Pharma Announces Proposal To Acquire Elan
3. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
4. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
5. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
6. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
7. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
8. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
9. Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
10. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
11. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... May 27, 2015 The amount Americans spend ... 2014 and with growth of 8% will reach $608 ... of pocket: directly on expenditures, co-pays as part of ... on premiums.  The publisher made its finding in its ... the United States . ...
(Date:5/28/2015)... PORTLAND, Oregon , May 28, 2015 ... titled, "Global Syphilis Testing Market - Size, Industry Analysis, Trends, Opportunities, ... market to reach $3.6 billion by 2020. The secondary ... segment through 2020. Latin America , ... Africa (LAMEA) market accounted for about 43% ...
(Date:5/28/2015)...  Service Strategies Corp., a leading provider of ... a global healthcare company that specializes in lifesaving ... nutrition, has achieved certification under the prestigious ... the seventh consecutive year. The ... stringent set of performance criteria and represent the ...
Breaking Medicine Technology:Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 3Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3Fresenius Kabi Recognized by Service Strategies Corp. for Technical Service Excellence 2Fresenius Kabi Recognized by Service Strategies Corp. for Technical Service Excellence 3
... Kan., May 21, 2012  BD (Becton, Dickinson and Company) ... technology company, and Heart to Heart International, a humanitarian ... second joint volunteer initiative to strengthen healthcare in Haiti.  ... world will build upon the progress made by their ...
... Inc. (NYSE MKT: INFU) ("InfuSystem" or the "Company"), the leading ... healthcare industry in the United States, today reported results for ... Revenues for the quarter ending March 31, 2012 were $14.3 ... of 2011.  Gross profit for the three months ending March ...
Cached Medicine Technology:BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti 2BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti 3InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 2InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 3InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 4InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 5InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 6InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 7InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 8InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues And $1.6 Million Of EBITDA For The First Quarter Of 2012 9
(Date:5/28/2015)... 28, 2015 Technology public relations ... (CNCK) as its agency of record to support ... app, SugarChecked. SugarChecked is an everyday grocery-shopping tool ... potential sugars they are putting in their bodies. ... of SugarChecked, execute media initiatives following launch, lead ...
(Date:5/28/2015)... Texas (PRWEB) May 28, 2015 ... excited to announce that the International Organization for ... Integrated Domain Group (BRIDG) Model version 3.2 as ... and its link with healthcare. This standard, which ... Standard (DIS) ballot, was unanimously approved on 24 ...
(Date:5/28/2015)... May 28, 2015 Success Strategies ... Application Process, **FDAnews Webinar**, June 23, 2015 — ... , On June 23, 2015, FDAnews is ... leading intellectual property attorneys from the international law ... for Biosimilars Approval: A Roadmap to the 351(k) ...
(Date:5/28/2015)... On Sunday, June 21, 2015, Colorado residents will participate ... the strength, passion and endurance of those facing Alzheimer’s ... this sunrise-to-sunset event symbolizes the challenging journey of those ... funds and awareness to advance the care, support and ... encouraged to create their own experience as they fundraise ...
(Date:5/28/2015)... Park Cities Pet Sitter is offering a 5-week ... starting Saturday, June 6th at 10:30am. The classes will ... in Dallas, with a maximum of six dogs allowed in ... with no class being held over the 4th of July ... this Intermediate-to-Advanced level class, dogs will solidify their practical behavior ...
Breaking Medicine News(10 mins):Health News:ContentChecked Selects PMBC Group To Launch New Nutrition App SugarChecked 2Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 2Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 3Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3
... warns public that basketball is the only sport that ... 5,12,000 emergency cases related to basketball. ,‘So ... to take steps to reduce their injury risk,’ said ... University Health System, Maywood, Ill. ,‘Bicycles ...
... a friend or a relative learns that she has cancer ... this, than about herself//. Questions as to how should to ... normal for them during her treatment often assail her. ... Emotionally Healthy Child When a Parent is Sick (McGraw Hill, ...
... was set up by the Zambia Pharmaceutical Regulatory Authority (PRA). ... safety of medicines during the post marketing// surveillance process. Pharmaco, ... reactions due to a particular drug. This is to inculcate ... Minister Ronnie Shikapwasha launched the body on the 16th of ...
... Morris the present American tobacco giant says that smoking ... pro-smoking campaigners declare that smoking can fight disease //. ... these are the new marketing strategies, which the cigarette ... down the risks. Recently they have also extensively funded ...
... the latest medicine kings in the treatment of many complex ... in the June issue of Angiology if pine bark extract ... of muscles. ,The reason and scientific basis behind ... to the muscles which speeds recovery after physical exercise. ...
... at the University of California have found that even a ... the child's iron //reserves and offset anemia for months. ... and poor nations. It is a problem particularly in developing ... first year, putting them at risk of serious developmental problems ...
Cached Medicine News:Health News:Basketball Top For Injurious Sports 2Health News:Basketball Top For Injurious Sports 3Health News:Helping a Family Going Through an Illness 2Health News:So Called Benefits of Nicotine 2Health News:A herbal delight for athletes in solving cramp and pain problems 2Health News:A herbal delight for athletes in solving cramp and pain problems 3Health News:Infants have better iron reserves if umbilical cord clamping is delayed 2Health News:Infants have better iron reserves if umbilical cord clamping is delayed 3
... MOBEE headboxes are the ... line of portable battery-powered ... a robust new mechanical ... software, XLTEK's standard MOBEE24plus ...
... Slit Lamp is an all-in-one instrument for observation, ... also allows the SL 130 to be used ... the possibility of operating the slit projector in ... right hand. The instrument configuration allows you to ...
... Lens Analyzers Model 350 and Model ... comprehensive lensometry for your practice. ,Simple ... (LA) gives fast and accurate lens ... prism lenses, contact lenses, polycarbonate and ...
... Bausch & Lomb provides fingertip control with ... handed delivery of the IOL directly into ... is assured by planar delivery. Leading haptic ... the capsular bag without sweeping motion. No ...
Medicine Products: